Sedative-hypnotic guideline, BHS

Slides:



Advertisements
Similar presentations
Prescription Drug Overdose National Perspective
Advertisements

Presenters: Cassandra Clement, Pharm.D., BCPS Orlando VA Medical Center Orlando, Florida Chris Stock, Pharm.D., BCPP George E. Wahlen Department of Veterans.
Innovative Approach of Managing High Risk Chronic Opioid Users in a Residency Practice Erin Inglis, MD a, Jessie Burch, PharmD b, Nida Awadallah, MD c,,
OVERDOSE SOLUTIONS 2013 OVERDOSE DATA FOR ALLEGHENY COUNTY Jennifer Janssen Manager Toxicology Laboratory Allegheny County Office of the Medical Examiner.
Opioid Safety Phillip Coffin, MD, MIA Director of Substance Use Research San Francisco Dept. of Public Health Assistant Clinical Professor University of.
Sublingual Buprenorphine and Pain
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2011.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2010.
John R. Kasich, Governor Tracy J. Plouck, Director Andrea Boxill, Deputy Director Andrea Boxill, Deputy Director Governor’s Cabinet Opiate Action Team.
Medical Director Jackson County Health and Human Services
Maine’s Prescription Monitoring Program Maine Benzodiazepine Study Group Conference 2007 UPDATE Daniel J. Eccher, MPH Project Coordinator.
SEDATIVES/HYPNOTICS BY KIMBERLY ROEMER. HISTORY OF SEDATIVES Sedatives have been around since the 1800’s. Potassium Bromide was used in 1830 as a sedative.
Diagnosis And Treatment Of Prescription Opioid Dependence Steven W. Clay, D.O. Associate Professor, Department of Family Medicine Ohio University College.
1 WASHINGTON STATE OPIOID GUIDELINES AND REGULATIONS Gary Franklin, MD, MPH Medical Director, WA Dept of Labor and Industries Chair, Washington State Agency.
Characteristics of Patients Using Extreme Opioid Dosages in the Treatment of Chronic Low Back Pain In this sample of 204 participants, 70% were female,
Good Prescribing to support Criminal Justice Interventions
+ Finding Balance: Preventing Medication Related Falls Through Appropriate Medication Use Chanel F. Agness, PharmD, Certified Geriatric Pharmacist
Opioid Use: What are the technological, clinical, ethical, and regulatory issues? Michael Von Korff Group Health Research Institute.
The term drug overdose (or simply overdose or OD) describes the ingestion or application of a drug or other substance in quantities that are excessive.
What are we doing in Southern Oregon? Concerns about opioid prescribing practices.
Opioid Use in Work-related Injuries Pacific Northwest Chapter - Association of Occupational Health Professionals (AOHP) January 4, 2011 Jaymie Mai, PharmD.
1 Benzodiazepines and Similar Drugs: Misuse, Abuse, and Dependence Randy Brown, MD University of Wisconsin, Madison Alcohol Medical Scholars Program Copyright.
Pharmacologic Considerations in the Treatment of Anxiety Disorders Presented by: Ann M. Hamer, PharmD, BCPP Date: 1/15/2015.
B ENZODIAZEPINE DEPENDENCE. WHO - ICD 10 C RITERIA FOR S UBSTANCE D EPENDENCE A definite diagnosis of dependence syndrome should usually be made only.
1 Alcohol and Substance Abuse Council of Jefferson County, Inc. 167 Polk Street, Suite 320 Watertown, New York Voice: ; Fax: ;
Origin and Process of Utah Guidelines Anna Fondario, MPH Utah Department of Health Violence and Injury Prevention Program.
Substance Misuse Dr. Graham Roberts. Content  Benzodiazepine management  Alcohol screening and brief intervention.  Substance misuse update.  Benzodiazepine.
2008 Update Presented by: Erin Johnson, MPH June, health.utah.gov/prescription.
Table 1. Prediction model for maximum daily dose of buprenorphine-naloxone in a 12-week treatment condition Baseline Predictors Maximum Daily Dose Standardized.
Long Term Use of Sedative-Hypnotics
S AN F RANCISCO C OUNTY : I MPROVING THE S AFETY OF S EDATIVE -H YPNOTIC P RESCRIBING Michelle Geier, PharmD Psychiatric and Substance Use Disorders Clinical.
Module IV - Identification of Patients for Buprenorphine Treatment BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS.
Prevention, Identification and Treatment of Opioid Use Disorders: A Personal Perspective Leah Bauer, MD Medical Director, Addiction Resource Center, Mid.
Clinical Management Course: Medical Complications of Alcoholism Peter R. Martin, M.D. Professor of Psychiatry and Pharmacology.
What the National Institute on Drug Abuse’s Clinical Trials Network Can Do for You? Major Findings from Medication Trials and Implications for Community-Based.
TNSAM Addiction Medicine. Data source: Tennessee Department of Health, Office of Health Statistics, Death Statistical System. Overdose deaths were defined.
Implementing a Urine Drug Screening Protocol to Teach Appropriate Opioid Prescribing in a Residency Practice STFM Annual Conference May 2, 2016 Nata Young,
Medicines that interact with alcohol See “Guidance on the administration of medicines to inpatients believed to have consumed alcohol ”
SOONERCARE PAIN MANAGEMENT PROGRAM. SOONERCARE PAIN MANAGEMENT PROGRAM The SoonerCare Pain Management Program is designed to equip SoonerCare providers.
Safe Prescribing of Opioids for the Management of Chronic Nonterminal Pain La Tanya Austin, PGY3.
Primary Care Models for Chronic Pain Treatment Melissa Weimer, DO, MCR.
Denis G. Patterson, DO ECHO Project April 20, 2016 CDC Guidelines for Prescribing Opioids for Chronic Pain.
PRESCRITION DRUG ABUSE and the ELDERLY GREGORY BUNT, M.D. Clinical Assistant Professor of Psychiatry NYU School of Medicine Interim Medical Director Samaritan.
Prepared by Dr. Ramin Safakish, MD, FRCPC – March 2016.
CDC Guideline for Prescribing Opioids for Chronic Pain- United States-2016 Gisele J. Girault, M.D. First Choice Healthcare Columbia, SC.
Current Concepts in Pain Management
Treatment of Pain on Opioid Prescribing in Utah, 2002–2009
Jessica E. Bates, Pharm.D. PGY-1 Pharmacy Resident
Cover slide.
THE OPIOID CRISIS Mississippi Board of Nursing
Barbiturates Meprobamate Paralehyde Chloral hydrate
Opioids in chronic pain
STOP! Safe Treatment of Pain
Delaware Dialogue: Addressing Substance Abuse DHMIC Summit 2017
Michael Panzer, MD ThedaCare Behavioral Health
Opioid-related Overdose in Allegheny County:
Opioid Prescribing & Monitoring
Medication Effects That May Impair Driving Ability
Management of Substance Use Disorders
Barbara Allison-Bryan, MD
2017 Opioid Prescriber Survey Preliminary Results
Lessons Learned In Opioid Treatment From the Pain Action Consulting Team.
Opioid Review and MAT Clinic
Opioids in Butte County
Assessing Opioid Use Disorder, part 1
Wider effects In any event, the incident itself is often quite small (and completely avoidable if you follow sops and concentrate (your reported learning)
Polypharmacy Pharmacist Consultant Liz Butterfield FRPharmS
Massachusetts Consultation Service for the Treatment of Addiction and Pain (MCSTAP) Offers real-time phone consultation to primary care practices on safe.
OHSU Addiction Medicine ECHO clinic
Tapering and Discontinuing Chronic Opioid Therapy
Presentation transcript:

Sedative-hypnotic guideline, BHS Judith Martin, Md Medical Director of Substance use services, SFDPH

Disclosures: No conflicts of interest for this talk.

Quality Management incident reports, 2010-2011 reviewed 55 deaths came to the attention of CBHS during 2010-2011, of patients enrolled in MMT. (most from incident report, collected by Melissa Bloom, QI) Focused on 14 opioid unintentional overdose deaths of patients in treatment (2 week window) Tried to obtain medical examiner report Collateral check of list from Phillip Coffin, Director of SUD Research, who is doing research on all city opioid overdose deaths.

2010/2011 accidental opioid overdose deaths reported by methadone clinics   DOD LDS/(cls) Open Age Sex Pgm 1 5-17-10 5-10-10 2005 65 m 2 4-13-11 4-12-11 59 3 2-23-11 2-20-11 1999 70 4 8-3-10 8-1-10 2002 5 5-28-11 5-29-11 f 6 10-25-10 10-24-10 40 7 2-9-11 2-7-11 2008 50 8 2-6-11 2-3-11 2006 60 9 12-6-10 11-29-10 2009 33 10 11-18-10 11-14-10 7mo 46 11 8-5-10 8-4-10 56 12 6-11-10 2007 45 13 1-8-11 2004 61 14 9-30-11 9-25-11 2010

Cause of death and tox screen COD/other me op Bz sed coc al   Coc/CVA x Mixed X Mo Prom p Pol/Copd (OD) (p) ? Traz mOD Quet Hc x/m Poly Sert,phenob Sert,quet P “poly” mOD/COPd mOD, Copd

Possible areas to address: 8/14 had sedatives present. 8/14 had cocaine present. Several noted lung disease as a co-morbidity. ( opioid overdose is related to breathing) Most deaths occurred in patients long into treatment, ie “they’ve been on it for years” isn’t protective, misconceived as safe.

Patients receiving buprenorphine at CBHS: Sedative/Hypnotic Prescriptions by CURES report: Michelle Geier, Pharm D

Study Findings: Buprenorphine and Sedative/Hypnotic Prescriptions Results Number of clients with a sedative or hypnotic 36 (19%) Average benzodiazepine dose (clonazepam equivalence) 2.5mg/day Benzodiazepine dose range 0.25mg – 15mg/day

Active Infoscriber Orders Dec 2013 Benzodiazepines and Zolpidem Comparison Drug Number of Active Orders Risperidone 1914 Trazodone 1623 Bupropion 1308 Sertraline 1277 Aripiprazole 1002 Citalopram 962 Drug Number of Active Orders Average Daily Dose (mg) Clonazepam 1549 1.72 Lorazepam 893 1.74 Zolpidem 574 9.10 Temazepam 138 24.18 Diazepam 68 13.78 Alprazolam 67 1.84

Next steps taken: Presented information to CBHS executive team and to Medication Use Improvement Committee (MUIC) which formed a subgroup that developed a benzodiazepine guideline. CBHS prescriber quarterly meeting on January 9th dedicated to presenting data, guideline, and getting BHS prescriber responses CURES registration drive Implementation varies Use active prescriptions as measure

Highlights of CBHS benzodiazepine guideline: (see handout) Components: - using non-sedative options - risk analysis - peer consultation check CURES when prescribing or considering benzodiazepines Evaluate for opioid use: pain, methadone, buprenorphine, etc. Evaluate for history of or active substance use disorder, including alcohol. Evaluate fragility, fall risk, age Discontinue, taper, consult if above checks positive.